Evidence map›Paper›PMID 40566581›Full record

ArticleLife (Basel, Switzerland)2025

CYTO-SV-ML: A Machine Learning Tool for Cytogenetic Structural Variant Analysis in Somatic Cell Type Using Genome Sequences.

Tao Zhang, Paul Auer, Stephen R Spellman, Jing Dong, Wael Saber, Yung-Tsi Bolon

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tao ZhangCIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP (National Marrow Donor Program), Minneapolis, MN 55401, USA.
Paul AuerDivision of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Stephen R SpellmanCIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP (National Marrow Donor Program), Minneapolis, MN 55401, USA.
Jing DongMedical College of Wisconsin Cancer Center, Milwaukee, WI 53226, USA.
Wael SaberCIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Yung-Tsi BolonCIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP (National Marrow Donor Program), Minneapolis, MN 55401, USA.ORCID 0000-0001-9414-6120

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Prognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantationK01HL164972 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Jing Dong · 2023 to 2026
$697k
HRSA HHS 75R60222C00011National Heart, Lung and Blood Institute U24CA076518National Institute of Allergy and Infectious Diseases U24CA076518NCI NIH HHS U24 CA076518NCI NIH HHS U24CA076518NHLBI NIH HHS K01 HL164972Office of Naval Research N00014-23-1-2057Office of Naval Research N00014-24-1-2057
6 · The paper itself

Abstract

(1) Background: Although whole genome sequencing (WGS) has enabled the comprehensive analyses of structural variants (SVs), more accurate and efficient methods are needed to distinguish large somatic SVs (SV size ≥ 1 Mb) traditionally detected through cytogenetic testing from germline SVs. (2) Methods: A customized machine learning pipeline (CYTO-SV-ML) under Snakemake automation workflow was developed with a user interface to identify somatic cytogenetic SVs in WGS data. And this tool was applied for characterizing structural variation profiles in the whole blood of patients with myelodysplastic syndromes (MDSs). Known SVs mapped from well-established open databases were split into training and validation subsets for an AUTO-ML machine learning model in a CYTO-SV-ML pipeline. (3) Results: The benchmarking performance of the CYTO-SV-ML pipeline on somatic cytogenetic SV classification displayed an area under the receiver operating characteristic curve (AUCROC) of 0.94 for translocations and 0.92 for non-translocations, a sensitivity of 0.83 for translocations and 0.85 for non-translocations, and a specificity of 0.96 for translocations and 0.82 for non-translocations. Our method (207 somatic cytogenetic SVs) outperformed a conventional SV calling pipeline (143 somatic cytogenetic SVs) in an independent validation of clinical cytogenetic records. In addition, the CYTO-SV-ML pipeline uncovered novel somatic cytogenetic SVs in 49 (89%) of 55 patients without successful clinical cytogenetic results. (4) Conclusions: Our study demonstrates the high-performance machine learning approach of CYTO-SV-ML on benchmarking SV classification from genomic sequencing data, and further validations of novel anomalies by orthogonal methods will be essential to unlock its full clinical potential of cytogenetic diagnostics.

Indexed as

cytogenetic abnormalitymachine learningsomatic cellsstructural variantstransplantwhole genome sequencing

Identifiers

PMID40566581
PMCPMC12194788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.